Literature DB >> 6327286

DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486.

S Bourgeois, M Pfahl, E E Baulieu.   

Abstract

RU-486 is an anti-fertility steroid which also has anti-glucocorticosteroid effects. RU-486 is shown to be a strong antagonist of the glucocorticosteroid-induced cytolytic response of the murine thymoma lines W7TB and T1M1b , and of the induction of mouse mammary tumor virus (MMTV) mRNA in T1M1b cells. The glucocorticosteroid receptor of W7 cells has high affinity for RU-486 (Kd = 3 X 10(-9) M) but the complex formed has low nuclear transfer capacity. Binding of RU-486, as compared with the glucocorticosteroid agonist triamcinolone acetonide, to mouse receptor results in a decreased affinity for DNA in general and a reduced specific recognition of a site in the promoter region of MMTV proviral DNA. The RU-486 complex formed with rat liver receptor exhibits the same behavior; in addition, it is shown that only a fraction of these complexes are activated by temperature and these form highly salt-sensitive interactions with DNA. These results indicate that the binding of RU-486 to glucocorticosteroid receptors mimics pharmacologically the properties of a class of receptor variants (nt-) which are non-functional and have reduced nuclear transfer and altered DNA binding capacity. These results substantiate the importance of DNA binding in receptor function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327286      PMCID: PMC557421          DOI: 10.1002/j.1460-2075.1984.tb01879.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  26 in total

1.  Interaction of glucocorticoid receptors from lymphoid cell lines with their nuclear acceptor sites.

Authors:  M Pfahl; T Sandros; S Bourgeois
Journal:  Mol Cell Endocrinol       Date:  1978-04       Impact factor: 4.102

Review 2.  Repressors.

Authors:  S Bourgeois; M Pfahl
Journal:  Adv Protein Chem       Date:  1976

3.  Glucocorticoid receptors: relations between steroid binding and biological effects.

Authors:  G G Rousseau; J D Baxter; G M Tomkins
Journal:  J Mol Biol       Date:  1972-06-14       Impact factor: 5.469

4.  Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines.

Authors:  S Bourgeois; R F Newby
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

5.  'Activation-labile' glucocorticoid-receptor complexes of a steroid-resistant variant of CEM-C7 human lymphoid cells.

Authors:  T J Schmidt; J M Harmon; E B Thompson
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

6.  Three-step purification of glucocorticoid receptors from rat liver.

Authors:  M V Govindan; B Manz
Journal:  Eur J Biochem       Date:  1980

7.  Purification of the glucocorticoid receptor from rat liver cytosol.

Authors:  O Wrange; J Carlstedt-Duke; J A Gustafsson
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

8.  Correlation of glucocorticoid receptor binding sites on MMTV proviral DNA with hormone inducible transcription.

Authors:  M Pfahl; D McGinnis; M Hendricks; B Groner; N E Hynes
Journal:  Science       Date:  1983-12-23       Impact factor: 47.728

9.  General features of steroid resistance on lymphoid cell lines.

Authors:  M Pfahl; R J Kelleher; S Bourgeois
Journal:  Mol Cell Endocrinol       Date:  1978-04       Impact factor: 4.102

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  23 in total

1.  Dexamethasone and mifepristone increase retroviral infectivity through different mechanisms.

Authors:  Victor Solodushko; Vira Bitko; Brian Fouty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-06-26       Impact factor: 5.464

Review 2.  Contragestion by antiprogestin RU 486: a review.

Authors:  E E Baulieu; A Ulmann; D Philibert
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

Review 3.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

4.  RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.

Authors:  R C Gaillard; A Riondel; A F Muller; W Herrmann; E E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

5.  Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury.

Authors:  Jin-Moo Lee; Ping Yan; Qingli Xiao; Shawei Chen; Kuang-Yung Lee; Chung Y Hsu; Jan Xu
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

6.  Thyroid hormone alters the DNA binding properties of chicken thyroid hormone receptors alpha and beta.

Authors:  M L Andersson; K Nordström; S Demczuk; M Harbers; B Vennström
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

7.  Interaction of newly synthesized antiprogesterone ZK98299 with progesterone receptor from human myometrium.

Authors:  A D'souza; I N Hinduja; S Kodali; V K Moudgil; C P Puri
Journal:  Mol Cell Biochem       Date:  1994-10-12       Impact factor: 3.396

8.  Dynamic regulation of mitochondrial function by glucocorticoids.

Authors:  Jing Du; Yun Wang; Richard Hunter; Yanling Wei; Rayah Blumenthal; Cynthia Falke; Rushaniya Khairova; Rulun Zhou; Peixiong Yuan; Rodrigo Machado-Vieira; Bruce S McEwen; Husseini K Manji
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

9.  Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway.

Authors:  Jennifer A Faralli; Debjani Gagen; Mark S Filla; Tania N Crotti; Donna M Peters
Journal:  Biochim Biophys Acta       Date:  2013-10-05

10.  Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone.

Authors:  Maria Fleseriu; James W Findling; Christian A Koch; Sven-Martin Schlaffer; Michael Buchfelder; Coleman Gross
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.